Liu CH, Chen CY, Su WW, Tseng KC, Lo CC, Liu CJ, Chen JJ, Peng CY, Shih YL, Yang SS, Huang CS, Huang KJ, Chang CY, Tsai MC, Kao WY, Fang YJ, Chen PY, Su PY, Tseng CW, Huang JJ, Lee PL, Lai HC, Hsieh TY, Chang CH, Huang YJ, Lee FJ, Chang CC, Kao JH. Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment. Gut. 2021 Jan 6:gutjnl-2020-323569. doi: 10.1136/gutjnl-2020-323569. Epub ahead of print. PMID: 33408122.

Hsu SJ, Yang SS, Kao JH. Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction? J Formos Med Assoc. 2020 Jan;119(1 Pt 1):3-11. doi: 10.1016/j.jfma.2019.09.006. Epub 2019 Oct 16. PMID: 31627984.

Lin HH, Liao SH, Huang YL, Liu KL, Kao JH. Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts. J Gastroenterol Hepatol. 2020 Jan;35(1):11. doi: 10.1111/jgh.14821. Epub 2019 Nov 11. PMID: 31711267.